KalVista Pharmaceuticals Q1 EPS $(0.66) Down From $(0.61) YoY

KalVista Pharmaceuticals (NASDAQ:KALV) reported quarterly losses of $(0.66) per share. This is a 8.2 percent decrease over losses of $(0.61) per share from the same period last year.

byBenzinga Newsdesk

September 9, 2021

1 minute read

KalVista Pharmaceuticals (NASDAQ:KALV) reported quarterly losses of $(0.66) per share. This is a 8.2 percent decrease over losses of $(0.61) per share from the same period last year.

Morgan Stanley Maintains Overweight on Farfetch, Lowers Price Target to $26

By Benzinga Newsdesk

October 25, 7:50 AM

Morgan Stanley analyst Lauren Schenk maintains Farfetch (NYSE:FTCH) with a Overweight and lowers the price target from $32 to $26.

FTCH

Rosenblatt Maintains Buy on Lumentum Holdings, Raises Price Target to $125

By Benzinga Newsdesk

March 24, 6:24 AM

Rosenblatt analyst Michael Genovese maintains Lumentum Holdings (NASDAQ:LITE) with a Buy and raises the price target from $115 to $125.

LITE

WISeKey Says Co’s Blockchain-Based Solutions Offer Decentralized Trust To Unlock Decentralized Internet 3.0 Via Trust Protocol Alliance

By Benzinga Newsdesk

October 11, 12:01 PM

WISeKey International Holding Ltd ("WISeKey", SIX: WIHN), a leading cybersecurity, IoT and AI company, today announced that Trust Protocol Association (the Association) is now fully operational. The

WKEY

Apollo Endosurgery Q2 EPS $(0.11) Beats $(0.20) Estimate, Sales $16.61M Beat $13.67M Estimate

By Benzinga Newsdesk

August 3, 4:32 PM

Apollo Endosurgery (NASDAQ:APEN) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.20) by 45 percent. This is a 63.33 percent increase over losses of $(0.30) per share from

APEN

KalVista Pharmaceuticals Q1 EPS $(0.66) Down From $(0.61) YoY

Related Posts

Morgan Stanley Maintains Overweight on Farfetch, Lowers Price Target to $26

Rosenblatt Maintains Buy on Lumentum Holdings, Raises Price Target to $125

WISeKey Says Co’s Blockchain-Based Solutions Offer Decentralized Trust To Unlock Decentralized Internet 3.0 Via Trust Protocol Alliance

Apollo Endosurgery Q2 EPS $(0.11) Beats $(0.20) Estimate, Sales $16.61M Beat $13.67M Estimate